Zenith Drugs Ltd
Zenith Drugs Ltd Share Price Today: Live Updates & Key Insights
Get insights on Zenith Drugs Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Zenith Drugs Ltd Share Price Chart
Zenith Drugs Ltd Fundamentals
Traded Volume: 36,800
Market Cap(Cr): 108
Avg Traded Price 79.69
1 Year return -42.20%
Upper Circuit 63.1
Lower Circuit 57
P/E TTM 15.00
P/B Ratio 4.00
Traded Value(Cr) 23.24
EPS TTM 4.176
Book value 4.176
Dividend 0.00%
Zenith Drugs Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Zenith Drugs Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Zenith Drugs Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W +1.04%
1M -0.63%
3M -6.24%
1Y -42.20%
YTD -25.39%
Zenith Drugs Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Zenith Drugs Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 8000.00
Day Before Yesterday 16000.00
1W Avg 19200.00
1M Avg 9160.00
3M Avg 10120.00
Zenith Drugs Ltd Technical Details
Zenith Drugs Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 59
Support 2 55
Support 3 53
Pivot Point : 61
Resistance 1 65
Resistance 2 67
Resistance 3 71
Zenith Drugs Ltd Corporate Actions
Zenith Drugs Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Zenith Drugs Ltd’s capital allocation strategies.
All
Ex-Date 17-Sep-2024 Type D Description 0.50/share@5.00% Record Date 18-Sep-2024 Ratio 5.00
Dividends
Announcement Date 17-Sep-2024 Ex Dividend Date 17-Sep-2024 Dividend(%) 5
Bonus
No Bonus has been declared by ZENITHDRUG
Splits
No Split has been declared by ZENITHDRUG
Others
Rights No Rights has been declared by ZENITHDRUG
Zenith Drugs Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Zenith Drugs Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Zenith Drugs Ltd's relative performance and valuation against major competitors.
Stock Name Denis Chem Lab Ltd ₹90.25 (-1.63%) M. Cap (Cr) 1.25 1 Yr Return (%) -43.38% P/E (TTM) 14.79 PB Ratio 1.47
Stock Name Par Drugs & Chemicals Ltd ₹98.73 (-0.45%) M. Cap (Cr) 1.21 1 Yr Return (%) -66.98% P/E (TTM) 8.58 PB Ratio 1.26
Stock Name Auro Laboratories Ltd ₹183.35 (-1.85%) M. Cap (Cr) 1.14 1 Yr Return (%) -28.48% P/E (TTM) 163.90 PB Ratio 2.66
Stock Name Zenith Drugs Ltd ₹63.15 (+1.85%) M. Cap (Cr) 1.08 1 Yr Return (%) -42.20% P/E (TTM) 15.12 PB Ratio 1.74
Stock Name Mercury Laboratories Ltd ₹889.00 (+4.86%) M. Cap (Cr) 1.07 1 Yr Return (%) -10.09% P/E (TTM) 28.29 PB Ratio 1.99
Stock Name Mangalam Drugs and Organics Ltd ₹63.28 (-0.83%) M. Cap (Cr) 1.00 1 Yr Return (%) -43.34% P/E (TTM) -10.26 PB Ratio 0.68
Zenith Drugs Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Zenith Drugs Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2025 -5.47 Mar 2024 -12.49 Mar 2023 -4.27 Mar 2022 4.91 Mar 2021 -0.89
PARTICULARS Investing Activities Mar 2025 -31.41 Mar 2024 25.52 Mar 2023 -2.05 Mar 2022 2.61 Mar 2021 -1.43
PARTICULARS Financing Activities Mar 2025 28.39 Mar 2024 -4.48 Mar 2023 6.30 Mar 2022 -0.83 Mar 2021 2.88
PARTICULARS Net Cash Flow Mar 2025 -8.48 Mar 2024 8.55 Mar 2023 -0.01 Mar 2022 6.69 Mar 2021 0.57
Zenith Drugs Ltd Shareholding Pattern
This shows the ownership breakdown of Zenith Drugs Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 69.98%
Public 30.03%
Other Institutions 0%
FII null%
Mutual Funds null%
About Zenith Drugs Ltd
Zenith Drugs Ltd was originally incorporated on November 15, 2000 as a Private Limited Company in the name of Zenith Drugs Private Limited issued by the Registrar of Companies, in the State of Madhya Pradesh, Gwalior. Subsequently, Company was converted into Public Limited and consequently, the name of Company was changed to `Zenith Drugs Limited' pursuance to issuance of a Fresh Certificate of Incorporation on September 13, 2023 by the Registrar of Companies, Gwalior. Zenith are a reputable pharmaceutical manufacturing and trading unit based out from Indore. With a diverse portfolio of formulations, the Company is specialized in manufacturing affordable and high quality medicines to meet the needs of patients. The Company is mainly engaged in the business of manufacturing and Trading of Medicines. It offers a wide range of formulations in various forms such as: ORS Powder; Liquid Orals; Oinments; Liquid Externals and Capsules. The Company was established in 2000 by the visionary founders, Late Shri Ramniklal Soni, and Mr. Mukesh Jain. Initially in 2001, Company started as a modest manufacturing house for oral and external formulations. However, recognizing the importance of quality and compliance, the Company swiftly shifted to a Schedule M GMP compliant unit in 2004 where it started the production of two lines which are liquid orals and ointments. In 2007, it expanded the product line by incorporating ORS Powder manufacturing into their operations. In 2016, the Company established present manufacturing facility, which holds WHO GMP certification. In 2019, it expanded the product line by introducing liquid externals and capsules. The Company propose Initial Public Fresh Issue upto 42,92,000 Equity Shares.
Managing Director
Sandeep Bhardwaj
Registered office K # 72/5 Village Muradpura, NA Depalpur, Indore, Madhya Pradesh, 453001
FAX :+91 84355 01867
Background
Incorporation Year 2000
Face Value ₹10.00
Market Lot 1600
FAQs on Zenith Drugs Ltd
How to buy Zenith Drugs Ltd shares on NSE?
To buy Zenith Drugs Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Zenith Drugs Ltd share price today?
The Zenith Drugs Ltd share price on NSE is ₹63.15 today.
What is the market cap of Zenith Drugs Ltd on NSE?
The company has a market capitalization of ₹108.29.
What is the PE & PB ratio of Zenith Drugs Ltd?
PE is 15 and PB is 4.
What is the 52 Week High and Low of Zenith Drugs Ltd shares?
Zenith Drugs Ltd stock price high: ₹110 Zenith Drugs Ltd stock price low: ₹47.15.